http://www.msnbc.msn.com/id/18591261/wid/11915773?GT1=10008
OxyContin maker misled on addiction risks
Purdue Pharma and former executives to pay $634.5 million in fines
May 10: NBC's Pete Williams reports on three former executives who pleaded guilty Thursday to misleading the public about OxyContin's risk of addiction.
ROANOKE, Va. - The maker of the powerful painkiller OxyContin and three of its current and former executives pleaded guilty Thursday to misleading the public about the drugâs risk of addiction, a federal prosecutor and the company said.
Purdue Pharma L.P., its president, top lawyer and former chief medical officer will pay $634.5 million in fines for claiming the drug was less addictive and less subject to abuse than other pain medications, U.S. Attorney John Brownlee said in a news release.
The plea agreement comes two days after the Stamford, Conn.-based company agreed to pay $19.5 million to 26 states and the District of Columbia to settle complaints that it encouraged physicians to overprescribe OxyContin.
--------------------------------------------------------------------------------
OxyContin maker misled on addiction risks
Purdue Pharma and former executives to pay $634.5 million in fines
May 10: NBC's Pete Williams reports on three former executives who pleaded guilty Thursday to misleading the public about OxyContin's risk of addiction.
ROANOKE, Va. - The maker of the powerful painkiller OxyContin and three of its current and former executives pleaded guilty Thursday to misleading the public about the drugâs risk of addiction, a federal prosecutor and the company said.
Purdue Pharma L.P., its president, top lawyer and former chief medical officer will pay $634.5 million in fines for claiming the drug was less addictive and less subject to abuse than other pain medications, U.S. Attorney John Brownlee said in a news release.
The plea agreement comes two days after the Stamford, Conn.-based company agreed to pay $19.5 million to 26 states and the District of Columbia to settle complaints that it encouraged physicians to overprescribe OxyContin.
--------------------------------------------------------------------------------
